home / stock / dbvt / dbvt news

DBVT News and Press, DBV Technologies S.A. From 06/13/22

Stock Information
Company Name: DBV Technologies S.A.
Stock Symbol: DBVT
Market: NASDAQ
Website: dbvtechnologies.com
Menu
DBVT DBVT Quote DBVT Short DBVT News DBVT Articles DBVT Message Board
Get DBVT Alerts

News, Short Squeeze, Breakout and More Instantly...
DBVT - CLSK, SI and CAN among premarket losers

MicroStrategy (MSTR) -25% as crypto market cap sinks below $1T. Astra Space (ASTR) -25% after latest mission failure. Qutoutiao (QTT) -21%. Marathon Digital Holdings (MARA) -17% as crypto market cap sinks below $1T. Bitfarms (BITF) -17% as cry...
DBVT - Cogent, IO Biotech top healthcare gainers; Fulcrum, Caribou lead losers' pack

Gainers: Cogent Biosciences (COGT) +56%. IO Biotech (IOBT) +9%. Celularity (CELU) +6%. PolarityTE (PTE) +6%. Aridis Pharmaceuticals (ARDS) +5%. Losers: Fulcrum Therapeutics (FULC) -48%. Caribou Biosciences (CRBU) -33%. DBV Technologies (DBVT) -18%. Card...

DBVT - DocuSign, GoodRx Holdings, Zeta Global Holdings among premarket losers' pack

DocuSign (DOCU) -25% on Q1 earnings release. RISE Education Cayman (REDU) -24%. Stitch Fix (SFIX) -15% on FQ3 earnings release. DBV Technologies (DBVT) -15%. Caribou Biosciences (CRBU) -13% amid new data for CAR-T therapy for non-Hodgkin lymphoma. Applied UV (AUV...

DBVT - Why DBV Technologies Stock Popped Again Today

A mere day after its stock rose by nearly 20%, biotech DBV Technologies (NASDAQ: DBVT) experienced a much stronger leap on Thursday. Shares of the company, which is developing a patch product to treat peanut allergies, ascended by nearly 80%. Still buoyed by the highly positive ...
DBVT - TAL, CRDF and VIRX among mid-day movers

Gainers: Power bridge Technologies (PBTS) +177%. Applied UV (AUVI) +50%. Cardiff Oncology (CRDF) +38%. DBV Technologies (DBVT) +28%. View (VIEW) +24%. Viracta Therapeutics (VIRX) +22%. Finger Motion (FNGR) +21%. Scien joy (SJ) +20%. Aero Clean Technologies (AERC) +19%. Akso Health Group (AHG)...

DBVT - DBV Technologies stock extends rally to a second day; co announces $194M financing

DBV Technologies (NASDAQ:DBVT) stock continued its rally on Thursday, adding ~28% to $2.31 in mid-day trading, after an 18.3% gain in the previous session. The company earlier in the day said that it was planning to raise $194M in gross proceeds via a private placement in ...

DBVT - Bluejay, DBV top healthcare gainers; Precision, Blueprint among losers' pack

Gainers: Bluejay Diagnostics BJDX +29%. DBV Technologies DBVT +12%. Arcellx (ACLX) +10%. Immix Biopharma (IMMX) +10%. AbCellera Biologics (ABCL) +8%. Losers: Precision BioSciences (DTIL) -10%. Blueprint Medicines (BPMC) -9%. Hutchmed (China) (HCM)&...
DBVT - DBV Technologies stock dips amid plans to raise $194M via equity financing

DBV Technologies (NASDAQ:DBVT) is planning to raise $194M in gross proceeds via a private investment in public equity (PIPE) financing. The company intends to sell ~32.86M ordinary shares, and pre-funded warrants to buy up to ~28.28M shares. The company said the ordinary shares will be sold a...

DBVT - DBV Technologies Announces Private Placement Financing of $194 Million

Montrouge, France, June 9, 2022 DBV Technologies Announces Private Placement Financing of $194 Million DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Global Select Market: DBVT), a clinical-stage biopharmaceutical company, today announced an aggregat...

DBVT - Why DBV Technologies Was a Big Winner on Wednesday

Shares of the unique biotech DBV Technologies (NASDAQ: DBVT) surged nearly 20% higher on Wednesday, far outpacing many peer stocks. That's because the company had some very encouraging news to impart about its key pipeline drug. DBV is developing a patch treatment for peanut all...
Previous 10 Next 10